Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04824469
Other study ID # EkisehirOsmangaziU
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 15, 2021
Est. completion date December 2022

Study information

Verified date November 2021
Source Eskisehir Osmangazi University
Contact Ebru Arslan Özdemir, PhD Student
Phone +90 531 420 96 53
Email ebruaarslan@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

2019 coronavirus disease (Covid-19) is a virus that emerged in Wuhan, China in late 2019, spread all over the world in a short time and causes severe acute respiratory syndrome and pneumonia. The World Health Organization classified the COVID-19 outbreak as an "international public health emergency" on January 30 and declared a global epidemic (pandemic) on March 11, 2020, due to the rapid spread of the virus all over the world. speed in the number of cases and deaths. Covidien-19 first cases were reported in Turkey on 10 March 2020 and the number of cases has risen steadily. The total number of COVID-19 cases worldwide on 31.01.2021; It was reported to be 101,917,147 and the total number of deaths was 2,205,515 (https://covid19.who.int/). Considering that the number of cases is constantly increasing, it is obvious that hospitals will not meet the entire epidemic burden. During this period, home care has emerged as an alternative way to effectively alleviate the epidemic burden. Home healthcare during the COVID-19 pandemic; Four roles have stood out: home diagnosis, follow-up, treatment, and care. Protective measures for home isolation of Covid-19 patients are the current method used to prevent the spread of cases. Possible or definite cases that do not have an indication for hospitalization, have a mild clinic and do not accompany severe chronic disease that may lead to a severe course of covid-19 are followed at home until their symptoms improve. In addition, patients who are hospitalized and meet discharge criteria can complete their recovery processes at home. Isolation is terminated on the 14th day at the earliest following the improvement of symptoms in patients who are followed at home. Reducing the contact of people, isolating certain and suspicious cases and effective use of personal protective equipment play an important role in combating the epidemic. It is thought that the training that COVID-19 cases to be followed up and treated at home will be effective in drug compliance, symptom management and quality of life will be effective in the management of the disease. 1251 / 5000 Çeviri sonuçları The universe of the research will be composed of people who apply to Zonguldak Atatürk State Hospital Emergency Service and Covid-19 Polyclinics. . The sample of the study, who accepted to participate in the study, was diagnosed with Covid-19 with U07.3 ICD code according to the results of PCR (Polymerase Chain Reaction) test and Thorax CT (Thorax CT), and was recommended to be followed up and treated at home by the Zonguldak Public Health Department It is planned to create individuals who meet the criteria.


Description:

G power analysis program was used to determine the sample size. The research will be conducted in two groups, an intervention and a control group. With professional support in calculating the sample size of the study, the sample size calculated at a 5% margin of error and a 95% confidence interval was found to be 128. However, against the possibility of sample losses during the follow-up process, the individual diagnosed with Covid-19 will be added to the number of samples by adding 20% (13 participants will be added for each group. 77 interventions in total, 77 controls) will be included in the study. Participants who meet the inclusion criteria and agree to participate in the study will be randomly assigned to the intervention and control groups. DATA COLLECTION TOOLS - Patient information form - Memorial Symptom Rating Scale - Covid-19 Symptom Assessment Inventory - Morisky Adaptation Scale (Muö) - World Health Organization Quality of Life Inventory Short Form Turkish Version - E-Health literacy scale - Opinion Form Regarding the Web Based Training Program - DISCERN Guide (Expert Opinions) - Website Content Evaluation Form (Expert Opinions)


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 128
Est. completion date December 2022
Est. primary completion date May 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Over the age of 18, - Does not have a communication problem that prevents participation in research or education, such as inability to understand / speak Turkish, - Being literate, - Residing in Zonguldak province, applying to hospitals in the province and diagnosed with Covid-19 according to PCR (Polymerase Chain Reaction) test and Thorax CT (Thorax computed tomography) results by the radiation teams and deemed appropriate for home follow-up by the Zonguldak Public Health Directorate, - Having active Internet access and actively using a computer / tablet or smartphone, - Patients who agree to participate in the study Exclusion Criteria: - No internet connection at home or on the phone, - Do not know how to use internet and computers, - Having a communication problem that prevents participation in research or education, such as inability to understand / speak Turkish, Patients who were previously diagnosed with Covid-19 and treated at home or in hospital, - With severe insufficiency (Heart failure, Kidney failure, Immune system failure) - Illiterate individuals will not be included in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
intervention group
web based training: By establishing a website, training on drug use, symptom management and quality of life will be provided.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Eskisehir Osmangazi University

Outcome

Type Measure Description Time frame Safety issue
Primary Pre-intervention measurements The Covid-19 symptom assessment inventory prepared by scanning the literature will be used to monitor the symptoms. The high score obtained from the inventory indicates the need for disease management. first day
Primary Pre-intervention measurements Morisky drug compliance scale to measure drug compliance: is a self-report scale consisting of four questions. The questions are answered as "yes (1 point) and no (0 point). Increasing the score obtained from the scale indicates that drug compliance is low. first day
Primary Pre-intervention measurements The Turkish version of the World Health Organization Quality of Life Inventory Short Form will be used to measure the quality of life. The scale is a Likert type form consisting of 27 questions. Higher total scores obtained from the scale indicate a good quality of life. first day
Secondary Post-intervention measurements The Covid-19 symptom assessment inventory prepared by scanning the literature will be used to monitor symptoms. The high score obtained from the inventory indicates that the need for disease management continues. 1. month
Secondary Post-intervention measurements Morisky drug compliance scale to measure drug compliance: is a self-report scale consisting of four questions. The questions are answered as "yes (1 point) and no (0 point). Increasing the score obtained from the scale indicates that drug compliance is low. 1. week
Secondary Post-intervention measurements The Turkish version of the World Health Organization Quality of Life Inventory Short Form will be used to measure the quality of life. The scale is a Likert type form consisting of 27 questions. Higher total scores obtained from the scale indicate a good quality of life. 1. month
See also
  Status Clinical Trial Phase
Recruiting NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Active, not recruiting NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure